Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Plaque Psoriasis Management: Evaluating Non-Steroidal Treatments and Current Data Trends : Episode 4
Opinion
Video
A Conversation on Combination Therapy, Safety Profiles, and Targeted IL-17 Systemic Treatments
Author(s):
The experts discuss combination therapy approaches, safety considerations, and targeted interleukin-17 systemic treatments for plaque psoriasis.
EP: 1.Navigating Plaque Psoriasis: Insights into the Psychosocial Impact and Evolving Treatment Landscape
EP: 2.Plaque Psoriasis Case Study: Patient Presentation, Treatment Selection, and Shared Decision-Making for Improved Outcomes
EP: 3.Empowering Patients with Plaque Psoriasis: Navigating Treatment Challenges Informed Patient Conversations and Decision Trees
Now Viewing
EP: 4.A Conversation on Combination Therapy, Safety Profiles, and Targeted IL-17 Systemic Treatments
EP: 5.Clinical Insights: Managing Psoriasis Treatment Dynamics and Strategic Therapy Switching Considerations
EP: 6.Head-to-Head Clinical Trials: Comparing Psoriasis Treatment Response Rates
EP: 7.TYK2 Inhibition and Deucravacitinib: Mechanism of Action, Safety Considerations, and Patient-Provider Conversations
EP: 8.Comparative Analysis: Deucravacitinib and Adalimumab in Psoriasis Treatment
EP: 9.Understanding IL-17 Therapies: Treatment Considerations, Rapid Response, and Impact on Plaque Psoriasis Location
EP: 10.Expert Insights into Managing Inadequate Response to Systemic Therapies: Strategies and Solutions
EP: 11.Long-Term Efficacy and Insights from POETYK PSO-1 Studies: Implications for Psoriasis Treatment
EP: 12.Achieving Durable Responses: Physician's Guide to Interpreting Long-Term Efficacy Data
EP: 13.When to Discontinue Treatment: Interpreting Safety Signals and Adverse Event Patterns
EP: 14.Updating Treatment Guidelines: Incorporating Novel Therapies to Address Unmet Needs
Related Videos
Related Content
